A typhoid vaccine shown in trials to be 79 percent effective, even after two years, is being recommended for use across South Asia, where the food and waterborne disease is widespread.
Nov 5, 2021
0
3
(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in ...
Oct 22, 2021
0
4
(HealthDay)—The incidence rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are similar for children and adults, but more infections among children are asymptomatic, according to a study published ...
Oct 15, 2021
0
22
Tuberculosis is on the rise again globally for the first time in a decade, linked to disruptions in access to healthcare because of the COVID pandemic, the World Health Orgnization said on Thursday.
Oct 14, 2021
0
6
The COVID-19 pandemic and its solution has only partially displaced other social and political concerns—and not persistently, despite the pandemic's high and constant media presence. This is shown by an international team ...
Oct 7, 2021
0
4
Chinese Americans and Laotian Americans were over 10 and 14 times more likely to be diagnosed with nasopharyngeal cancer, respectively, than non-Hispanic white Americans, with incidence rates surpassing other Asian American ...
Oct 6, 2021
0
16
A new study found that incidence rates for malignant brain and other central nervous system (CNS) tumors declined by 0.8% annually during 2008 through 2017 in the United States for all ages combined. The decline was driven ...
Aug 24, 2021
0
0
(HealthDay)—Incident cases of mesothelioma and deaths associated with mesothelioma increased worldwide during 1990 to 2017, according to a study published online Aug. 11 in JAMA Network Open.
Aug 11, 2021
0
3
With COVID-19 cases again on the rise, German officials said on Monday said that authorities need a "broader focus" beyond the country's infection rate to fully gauge the impact the pandemic is having on the health system ...
Jul 12, 2021
0
2
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
Jul 9, 2021
0
4
